IBB240628P139000
- 1.40
- +0.30+27.27%
iShares Biotechnology ETF Newsroom
Rising Drug Costs Force a Third of Americans to Leave Prescriptions Unfilled: Report
Insulet Tops S&P 500 Growth Chart for Q2 as It Gains Market Share in the Diabetes Space
5 Analysts Assess IQVIA Hldgs: What You Need To Know
What's Going On With Moderna Stock Friday?
IQVIA Hldgs Analyst Ratings
What's Going On With Regeneron Pharmaceuticals Stock On Friday?
Carisma Jumps as Drug Discovery Under Moderna Deal Leads to $2M Payment
Sector Update: Health Care Stocks Higher Pre-Bell Friday
CHMP Recommends Regeneron Lymphoma Antibody Drug for Conditional Approval
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday Ahead of Key Inflation Report
Today's Morning Movers and Top Ratings: NKE, DE, MRNA, SAP and More
Moderna RSV Vaccine Endorsed in EU
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields
Regeneron's Odronextamab Receives Opinion From EMA for Lymphoma Treatment
Wells Fargo Updated Its Signature Picks, With Vertex Pharma and AvalonBay as Adds
Amgen Analyst Ratings
Peering Into Alnylam Pharmaceuticals's Recent Short Interest
AbbVie/Genmab's Epkinly FDA Approval Is A Positive Step, Analyst Says Additional Expansion Opportunities Underway
In-Depth Examination Of 10 Analyst Recommendations For Moderna
First Inhaled COPD Therapy In Over 2 Decades - FDA Approves Verona Pharma's First Commercial Product